CAMBRIDGE – Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Swiss Federal Government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022. These doses are in addition to the initial seven million doses of booster vaccine the Swiss Federal …
SYDNEY (Reuters) The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic. “There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,” Moderna Chief Executive …
LONDON (Reuters) The University of Oxford yesterday said there was no evidence that vaccines would not prevent severe disease from Omicron, but that it was ready to rapidly develop an updated version of its vaccine developed with AstraZeneca if necessary. Earlier on Tuesday, the head of drugmaker Moderna said that COVID-19 shots were unlikely to be as effective against the …
